ZA909043B - Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders - Google Patents

Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders

Info

Publication number
ZA909043B
ZA909043B ZA909043A ZA909043A ZA909043B ZA 909043 B ZA909043 B ZA 909043B ZA 909043 A ZA909043 A ZA 909043A ZA 909043 A ZA909043 A ZA 909043A ZA 909043 B ZA909043 B ZA 909043B
Authority
ZA
South Africa
Prior art keywords
asthma
treatment
analogs
skin disorders
certain skin
Prior art date
Application number
ZA909043A
Other languages
English (en)
Inventor
John B Cheng
B Cheng John
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA909043B publication Critical patent/ZA909043B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA909043A 1989-11-13 1990-11-12 Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders ZA909043B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1989/005221 WO1991007177A1 (fr) 1989-11-13 1989-11-13 Derives de pyrimidone et analogues pour le traitement de l'asthme et de certaines maladies de la peau

Publications (1)

Publication Number Publication Date
ZA909043B true ZA909043B (en) 1992-06-24

Family

ID=22215372

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA909043A ZA909043B (en) 1989-11-13 1990-11-12 Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders

Country Status (17)

Country Link
US (1) US5342842A (fr)
EP (1) EP0428313B1 (fr)
JP (2) JPH0662412B2 (fr)
KR (1) KR930001832B1 (fr)
AT (1) ATE101040T1 (fr)
AU (1) AU627631B2 (fr)
CA (1) CA2029704C (fr)
DE (1) DE69006452T2 (fr)
DK (1) DK0428313T3 (fr)
HU (1) HU212311B (fr)
IE (1) IE63472B1 (fr)
IL (1) IL96260A (fr)
MY (1) MY111474A (fr)
NZ (1) NZ236038A (fr)
PT (1) PT95854B (fr)
WO (2) WO1991007177A1 (fr)
ZA (1) ZA909043B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH31245A (en) * 1991-10-30 1998-06-18 Janssen Pharmaceutica Nv 1,3-Dihydro-2H-imidazoÄ4,5-BÜ-quinolin-2-one derivatives.
US5814651A (en) * 1992-12-02 1998-09-29 Pfizer Inc. Catechol diethers as selective PDEIV inhibitors
NZ257955A (en) * 1992-12-02 1996-05-28 Pfizer Catechol diethers pharmaceutical compositions
US5482944A (en) * 1993-07-13 1996-01-09 Pfizer Inc. Pyrimidones and imidazolinones for treatment of shock
US5502072A (en) * 1993-11-26 1996-03-26 Pfizer Inc. Substituted oxindoles
JP2818820B2 (ja) * 1993-11-26 1998-10-30 ファイザー・インク. 抗炎症剤としての3−アリール−2−イソオキサゾリン類
WO1995024192A1 (fr) * 1994-03-09 1995-09-14 Pfizer Inc. Composes d'isoxazoline agissant comme inhibiteurs de 5-lipoxygenase
DE69503769T2 (de) * 1994-03-09 1998-12-03 Pfizer Inc., New York, N.Y. Isoxazoline verbindung zur hemmung tnf-freigabe
US5563143A (en) * 1994-09-21 1996-10-08 Pfizer Inc. Catechol diether compounds as inhibitors of TNF release
JP4373497B2 (ja) 1996-06-19 2009-11-25 ローン−プーラン・ロレ・リミテツド 置換されたアザビシクロ化合物、ならびにtnfおよびサイクリックampホスホジエステラーゼ産生の阻害剤としてのそれらの使用
EP0924204A4 (fr) 1996-08-27 2002-10-23 Nikken Chemicals Co Ltd Derives du 2-phenylmorpholin-5-one et composition pharmaceutique les comprenant
CA2402384A1 (fr) * 2000-03-16 2001-09-20 Inflazyme Pharmaceuticals Ltd. Inhibiteurs benzyles de pde4

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2401446A1 (de) * 1973-01-16 1974-07-25 Voorhees Pharmazeutische zubereitungen zur linderung von hautproliferationserkrankungen
SU888821A3 (ru) * 1976-12-03 1981-12-07 Шеринг Аг (Инофирма) Способ получени 5-(замещенный фенил)-оксазолидинонов или их серусодержащих аналогов
DE3315797A1 (de) * 1983-04-30 1984-10-31 Beiersdorf Ag, 2000 Hamburg Substituierte phenyl-2-(1h)-pyrimidinone, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen
GB8416140D0 (en) * 1984-06-25 1984-08-01 Fujisawa Pharmaceutical Co Pyrimidinone derivatives
FI875724A0 (fi) * 1986-04-29 1987-12-28 Pfizer Av kalcium oberoende camp fosfodiesteras-inhibitordepressant.

Also Published As

Publication number Publication date
ATE101040T1 (de) 1994-02-15
WO1991007177A1 (fr) 1991-05-30
EP0428313B1 (fr) 1994-02-02
IL96260A0 (en) 1991-08-16
IE904058A1 (en) 1991-05-22
IL96260A (en) 1995-11-27
EP0428313A3 (en) 1991-11-06
HU9201575D0 (en) 1993-04-28
DE69006452D1 (de) 1994-03-17
KR930001832B1 (ko) 1993-03-15
DK0428313T3 (da) 1994-03-07
US5342842A (en) 1994-08-30
AU6653690A (en) 1991-08-01
NZ236038A (en) 1997-03-24
KR910009259A (ko) 1991-06-28
AU627631B2 (en) 1992-08-27
HUT70052A (en) 1995-09-28
PT95854B (pt) 1997-11-28
CA2029704C (fr) 1995-02-07
JPH0748255A (ja) 1995-02-21
WO1991007178A1 (fr) 1991-05-30
JPH03209322A (ja) 1991-09-12
CA2029704A1 (fr) 1991-05-14
DE69006452T2 (de) 1994-05-11
MY111474A (en) 2000-06-30
JPH0662412B2 (ja) 1994-08-17
JP2514163B2 (ja) 1996-07-10
PT95854A (pt) 1991-09-13
HU212311B (en) 1996-05-28
IE63472B1 (en) 1995-04-19
EP0428313A2 (fr) 1991-05-22

Similar Documents

Publication Publication Date Title
PL292101A1 (en) Method of obtaining novel derivatives of cyclopentylpurine and cyclopentylpyrimidine
IL114894A0 (en) Endothelin antagonists
ZA944739B (en) Amide and urea derivatives having anti-hypercholesteremic activity their preparation and their therapeutic uses
AU627631B2 (en) Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders
HU9301197D0 (en) Medical preparatives containing quinoline and quinazoline derivatives as well as new quinoline and quinazoline derivatives
ZA89389B (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
GR3005990T3 (fr)
ES2007064A6 (es) Un procedimiento para la obtencion de 4(3h)-oxo-5,6,8-tetrahidropirido (2,3-d)pirimidinas
AU641686B2 (en) Benzanilides
GR3019893T3 (en) Novel S-adenosyl methionine decarboxylase inhibitors
DE3666223D1 (en) Anticonvulsant agents
AU631209B2 (en) Carboxamide derivatives
HU912216D0 (en) Process for the production of purinyl-and pirimidinyl - tetrahydrofurane derivatives and medical preparations containing them
EP0449011A3 (en) Stereoselective process for the preparation of 2-amino-ethanol derivatives having a central analgesic activity and intermediates thereof
ZA885358B (en) Uricosuric composition
EP0272849A3 (en) Use of 2-oxo-imidazolidine derivatives in the treatment of kidney diseases
EP0370821A3 (fr) Dérivés de 1,4-dihydropyridine
LU88449I2 (fr) Fleroxacine et ses dérivés pharmaceutiquement acceptables.